Addex Therapeutics to Release Third Quarter 2023 Financial :

Geneva, Switzerland, November 23, 2023 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric...

Related Keywords

Switzerland , United States , Geneva , Genè , Swiss , American , Tim Dyer , Mike Sinclair , Mikhail Kalinichev , Nasdaq , Swiss Exchange , Third Quarter , Translational Science , Addex Therapeutics , Release Third Quarter , Provides Corporate Update , Conference Call , Participant Dial In , American Depositary Shares , Executive Officer , Halsin Partners , Swiss Stock Exchange Adxn ,